Therapeutic levels of human factor VIII and IX using HIV-1–based lentiviral vectors in mouse liver
Open Access
- 1 August 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (3) , 1173-1176
- https://doi.org/10.1182/blood.v96.3.1173
Abstract
Lentiviral vectors have the potential to play an important role in hemophilia gene therapy. The present study used human immunodeficiency virus (HIV)-based lentiviral vectors containing an EF1 enhancer/promoter driving human factors VIII (hFVIII) or IX (hFIX) complementary DNA expression for portal vein injection into C57Bl/6 mice. Increasing doses of hFIX-expressing lentivirus resulted in a dose-dependent, sustained increase in serum hFIX levels up to approximately 50-60 ng/mL. Partial hepatectomy resulted in a 4- to 6-fold increase (P < 0.005) in serum hFIX of up to 350 ng/mL compared with the nonhepatectomized counterparts. The expression of plasma hFVIII reached 30 ng/mL (15% of normal) but was transient as the plasma levels fell concomitant with the formation of anti-hFVIII antibodies. However, hFVIII levels were persistent in immunodeficient C57Bl/6 scid mice, suggesting humoral immunity-limited gene expression in immunocompetent mice. This study demonstrates that lentiviral vectors can produce therapeutic levels of coagulation factors in vivo, which can be enhanced with hepatocellular proliferation.Keywords
This publication has 28 references indexed in Scilit:
- Use of a Liver-Specific Promoter Reduces Immune Response to the Transgene in Adenoviral VectorsHuman Gene Therapy, 1999
- Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in miceHepatology, 1998
- Effects of Keratinocyte and Hepatocyte Growth FactorIn Vivo:Implications for Retrovirus-Mediated Gene Transfer to LiverHuman Gene Therapy, 1998
- Sustained expression of genes delivered directly into liver and muscle by lentiviral vectorsNature Genetics, 1997
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsNature Genetics, 1997
- Construction of Human Factor IX Expression Vectors in Retroviral Vector Frames Optimized for Muscle CellsHuman Gene Therapy, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Retroviral-Mediated in vivo Gene Transfer into Muscle Cells and Synthesis of Human Factor IX in MiceIntervirology, 1995
- In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient DogsScience, 1993
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences, 1993